, Tracking Stock Market Picks
Enter Symbol:
Rating: UNIS
Buy $4.75

Unilife Corporation (NASDAQ: UNIS) rated to Buy with price target $4.75 by Ladenburg Thalmann

Thursday,  Nov 29, 2012  10:25 AM ET by Dave Ficere

Ladenburg Thalmann rated Unilife
Corporation (NASDAQ: UNIS) to Buy with price target $4.75.

Unilife Corporation engages in the design, development, manufacture, and supply of healthcare safety products for medical device and pharmaceutical industries in Australia and the United States. The company?s products include the Unifill syringe, a ready-to-fill (prefillable) syringe with integrated safety features for injectable drug filling and packaging systems; and clinical and prefilled safety syringes with automatic and controlled needle retraction features. It also provides medical device contract manufacturing services for healthcare and pharmaceutical suppliers. Unilife Corporation is based in Lewisberry, Pennsylvania.

Our Research Department takes a fresh, critical approach to analyzing primary sources and developing proprietary research. Many individuals, institutions, portfolio managers and hedge fund managers, on all levels, have been neglected by brokerage firms ignoring the demands for unbiased research. Ladenburg Thalmann provides a superior branded in-depth research product geared only to action-oriented investment ideas. Ladenburg Thalmann’s proprietary equity research tries to uncover crucial information before the rest of the Street. Our analysts concentrate on uncovered and under-covered stocks and have a small to mid-cap focus. We will not shy away from large cap names as long as we can bring value to our clients through timely, differentiated ideas.

RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy